ACE2 and metabolic dysfunction-associated steatotic liver disease: For example, Meijnikman et al. describe increased hepatic ACE2 expression in patients with non-alcoholic fatty liver disease (NAFLD) [9], and Paizis et al. similarly find markedly increased hepatocyte ACE2 expression in hepatitis B virus (HBV)-related cirrhosis [10].